Activation of the inflammatory cascade leads to the activation of serine kinases and the release of other molecules, such as galectin-3 and leukotriene B4 (LTB4), which directly decrease insulin sensitivity, thus resulting in insulin resistance (84, 85). The gene discussed is INS; the disease is Insulin resistance.